We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00442533
Recruitment Status : Completed
First Posted : March 2, 2007
Last Update Posted : April 28, 2017
Sponsor:
Collaborators:
Excel Diagnostic Imaging Clinics
Radiomedix, Inc.
CHI St. Luke's Health, Texas
Information provided by (Responsible Party):
Ebrahim Delpassand, Radio Isotope Therapy of America

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 30, 2014
  Study Completion Date : December 29, 2015